Antinuclear antibody detection by automated multiplex immunoassay in untreated patients at the time of diagnosis.
about
The uses and misuses of multiplex autoantibody assays in systemic autoimmune rheumatic diseasesAutoantibodies in systemic sclerosis: unanswered questionsSystemic lupus erythematosus diagnostics in the 'omics' eraMechanisms of Autoantibody-Induced Pathology.The Use of Poly-L-Lysine as a Capture Agent to Enhance the Detection of Antinuclear Antibodies by ELISA.Stress granules and RNA processing bodies are novel autoantibody targets in systemic sclerosis.New platform technology for comprehensive serological diagnostics of autoimmune diseasesOriginal approach for automated quantification of antinuclear autoantibodies by indirect immunofluorescence.Anti-nuclear antibodies in daily clinical practice: prevalence in primary, secondary, and tertiary care.Autoantibodies in the grocery shop: does quantity matter?Standardization of anti-DNA antibody assays.Current concepts and future directions for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies.Clinical and serological associations of autoantibodies to the Ku70/Ku80 heterodimer determined by a novel chemiluminescent immunoassay.Belgian recommendations on ANA, anti-dsDNA and anti-ENA antibody testing.Antinuclear antibody testing - misunderstood or misbegotten?Personalized medicine in rheumatology: the paradigm of serum autoantibodies.Myalgic encephalomyelitis/chronic fatigue syndrome and gulf war illness patients exhibit increased humoral responses to the herpesviruses-encoded dUTPase: Implications in disease pathophysiology.Diagnostic Evaluation of ELISA and Chemiluminescent Assays as Alternative Screening Tests to Indirect Immunofluorescence for the Detection of Antibodies to Cellular Antigens.Second generation analysis of antinuclear antibody (ANA) by combination of screening and confirmatory testing.Rpp25 is a major target of autoantibodies to the Th/To complex as measured by a novel chemiluminescent assay.Predictors of outcome in a large retrospective cohort of patients with transverse myelitis.Clinical comparison of QUANTA Flash dsDNA chemiluminescent immunoassay with four current assays for the detection of anti-dsDNA autoantibodies.Evaluation of ENA-6 Profile by ELISA Immunoassay in Patients with Systemic Lupus Erythematodes.Highlights on novel technologies for the detection of antibodies to Ro60, Ro52, and SS-B.Aicardi-Goutières syndrome harbours abundant systemic and brain-reactive autoantibodies.Autoantibodies Associated With Connective Tissue Diseases: What Meaning for Clinicians?Detection of antinuclear antibodies: added value of solid phase assay?Automated Processing and Evaluation of Anti-Nuclear Antibody Indirect Immunofluorescence Testing.Linee guida per l’utilizzo dei test autoanticorpali nella diagnosi e nel monitoraggio delle malattie autoimmuni reumatiche sistemiche. Revisione 2015
P2860
Q26991822-9F4CCC49-2A17-4B87-A2BB-C3EF852281CBQ28085026-E4DACACD-106B-408F-B750-9FEAA3949A0BQ33644106-791338DE-6649-428F-89A8-10170387E1EBQ33740580-19E1507E-0902-473A-B727-37D47F589787Q36127922-0287EC34-2C2A-4C15-8445-32FC7ED346BDQ36493693-EED0AF50-A826-4AB0-B5CD-8C997D4C5993Q36505735-5BFE3580-BA6C-476C-8DFB-B986E7954E09Q37425948-6F85B23F-9AD5-4C86-AE3B-37DE1C22A593Q37704590-EC9FFAF2-199C-47E6-B8DC-1B66410A0EE2Q38097752-34584463-CE4E-4427-AFD3-7944E2C2F8E9Q38098438-0B2F46F7-4744-4B38-B456-84ED8249FE56Q38215525-5BE774F4-FC99-452F-A55F-F7CD5BE5E05FQ38851103-11492CA6-F3D7-4FDD-A44D-BE0554AC2AA3Q39005151-FCE31F80-AD07-4320-A55F-69EB983A0FE1Q39328604-E4E76284-2051-41E0-9F4D-86F8FDBE0A21Q39432157-46D446C8-81F1-492E-AA3B-3D4A095A255AQ40288220-01EC524F-F680-4D49-AA7D-E3ADE00A4628Q40695273-E26F66B0-7A9B-455C-B2A0-D71E73991591Q41197918-BAD4FB11-4870-423C-9295-D11C1915992BQ41532980-C2BF3476-2FC3-4CD8-89F1-2D90C14FD9C3Q41992411-D9F9769B-51DE-44F5-AB2D-29892FA38CF6Q42145558-28A5022A-15E7-4F49-8F30-C23503DF4375Q42410966-B3D0F802-8F9D-4510-872F-8883A868C854Q42812734-BCDF60EA-F5FF-4303-8316-0AA70325EBA5Q48728863-938DB57E-C703-415E-9533-5EB29128ECCCQ52597638-6E3E71B5-3752-48B3-AF4D-FDF31AC3D741Q54565508-F7E4890B-E78A-4245-93F2-13EEA64FFC94Q55279741-B7B2B55B-4C21-4325-8976-F9E77FF1DE61Q58985221-B5184824-5A1D-46EC-BCC6-6882529B6B22
P2860
Antinuclear antibody detection by automated multiplex immunoassay in untreated patients at the time of diagnosis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Antinuclear antibody detection ...... ents at the time of diagnosis.
@en
Antinuclear antibody detection ...... ents at the time of diagnosis.
@nl
type
label
Antinuclear antibody detection ...... ents at the time of diagnosis.
@en
Antinuclear antibody detection ...... ents at the time of diagnosis.
@nl
prefLabel
Antinuclear antibody detection ...... ents at the time of diagnosis.
@en
Antinuclear antibody detection ...... ents at the time of diagnosis.
@nl
P2093
P921
P1433
P1476
Antinuclear antibody detection ...... ents at the time of diagnosis.
@en
P2093
Daniel Blockmans
Godelieve Mariën
Katrijn Op De Beéck
Patrick Verschueren
Pieter Vermeersch
René Westhovens
Xavier Bossuyt
P304
P356
10.1016/J.AUTREV.2012.02.013
P577
2012-02-23T00:00:00Z